1
|
Figueiró Longo JP, Camargo NS, Andrade SS, Vasconcelos AG, Sa Leite JR. Nanotechnological innovations in dermo-cosmetics: lessons for nanomedicine advancement. Nanomedicine (Lond) 2024:1-5. [PMID: 39011844 DOI: 10.1080/17435889.2024.2367959] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2023] [Accepted: 06/11/2024] [Indexed: 07/17/2024] Open
Affiliation(s)
- João Paulo Figueiró Longo
- Department of Genetics & Morphology, Institute of Biological Sciences, University of Brasília, Brasília, Brazil
- Department of Science & Innovation, Glia Innovation, Goiânia, Goiás, Brazil
| | - Nichollas Serafim Camargo
- Department of Science & Innovation, Glia Innovation, Goiânia, Goiás, Brazil
- Plateinnove Biotechnology, Sorocaba, São Paulo, Brazil
| | - Sheila Siqueira Andrade
- Department of Science & Innovation, Glia Innovation, Goiânia, Goiás, Brazil
- Plateinnove Biotechnology, Sorocaba, São Paulo, Brazil
| | - Andreanne Gomes Vasconcelos
- Research Center in Applied Morphology and Immunology, NuPMIA, Faculty of Medicine, University of Brasilia, UnB, Brasília, DF, Brazil
- People & Science Research, Development and Innovation LTDA, Brasília DF, Brazil
| | - José Roberto Sa Leite
- Research Center in Applied Morphology and Immunology, NuPMIA, Faculty of Medicine, University of Brasilia, UnB, Brasília, DF, Brazil
- People & Science Research, Development and Innovation LTDA, Brasília DF, Brazil
| |
Collapse
|
2
|
Siqueira Andrade S, Faria AVDS, Augusto Sousa A, da Silva Ferreira R, Camargo NS, Corrêa Rodrigues M, Longo JPF. Hurdles in translating science from lab to market in delivery systems for Cosmetics: An industrial perspective. Adv Drug Deliv Rev 2024; 205:115156. [PMID: 38104897 DOI: 10.1016/j.addr.2023.115156] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2023] [Revised: 12/01/2023] [Accepted: 12/09/2023] [Indexed: 12/19/2023]
Abstract
In recent decades, a sweeping technological wave has reshaped the global economic landscape. Fueled by the unceasing forces of digital innovation and venture capital investment, this transformative machine has left a significant mark across numerous economic sectors. More recently, the emergence of 'deep tech' start-ups, focusing on areas such as artificial intelligence, nanotechnology, and biotechnology, has infused a fresh wave of innovation into various sectors, including the pharmaceutical and cosmetic industry. This review explores the significance of innovation within the cosmetics sector, with a particular emphasis on delivery systems. It assesses the crucial process of bridging the gap between research and the market, particularly in the translation of nanotechnology into tangible real-world applications. With the rise of nanotechnology-based beauty ingredients, we can anticipate groundbreaking advancements that promise to surpass consumer expectations, ushering in a new era of unparalleled innovation in beauty products.
Collapse
Affiliation(s)
- Sheila Siqueira Andrade
- PlateInnove Biotechnology, Sorocaba, São Paulo, Brazil; Department of Science and Innovation, Glia Innovation, Goiânia, Goiás, Brazil
| | - Alessandra Valéria de Sousa Faria
- Department of Biochemistry and Tissue Biology, Institute of Biology, Universidade Estadual de Campinas (UNICAMP), Campinas, SP, Brazil
| | | | | | | | - Mosar Corrêa Rodrigues
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasilia, Brazil
| | - João Paulo Figueiró Longo
- Department of Science and Innovation, Glia Innovation, Goiânia, Goiás, Brazil; Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasilia, Brazil.
| |
Collapse
|
3
|
Eissa RG, Eissa NG, Eissa RA, Diab NH, Abdelshafi NA, Shaheen MA, Elsabahy M, Hammad SK. Oral proniosomal amitriptyline and liraglutide for management of diabetic neuropathy: Exceptional control over hyperglycemia and neuropathic pain. Int J Pharm 2023; 647:123549. [PMID: 37890645 DOI: 10.1016/j.ijpharm.2023.123549] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2023] [Revised: 09/19/2023] [Accepted: 10/23/2023] [Indexed: 10/29/2023]
Abstract
Exploitation of nanocarriers provides a compartment for enclosing drugs to protect them from degradation and potentiate their therapeutic efficiency. In the current study, amitriptyline- and liraglutide-loaded proniosomes were constructed for management of diabetic neuropathy, a serious complication associated with diabetes, that triggers spontaneous pain in patients and results in impaired quality of life. The developed therapeutic proniosomes were extensively characterized via dynamic light scattering, scanning electron microscopy, transmission electron microscopy, and Fourier transform-infrared spectroscopy. High entrapment efficiency could be attained for both drugs in the proniosomes, and the reconstituted amitriptyline- and liraglutide-loaded niosomes possessed spherical morphology and particle sizes of 585.3 nm and 864.4 nm, respectively. In a diabetic neuropathy rat model, oral administration of the developed amitriptyline- and liraglutide-loaded proniosomes significantly controlled blood glucose levels, reduced neuropathic pain, oxidative stress and inflammatory markers, and improved histological structure of the sciatic nerve as compared to the oral and subcutaneous administration of amitriptyline and liraglutide, respectively. Loading of the tricyclic antidepressant amitriptyline and the antidiabetic peptide liraglutide into proniosomes resulted in exceptional control over hyperglycemia and neuropathic pain, and thus could provide an auspicious delivery system for management of neuropathic pain and control of blood glucose levels.
Collapse
Affiliation(s)
- Rana G Eissa
- Department of Biochemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt
| | - Noura G Eissa
- Department of Pharmaceutics, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt; Badr University in Cairo Research Center, Badr University in Cairo, Badr City, Cairo 11829, Egypt
| | - Rana A Eissa
- Badr University in Cairo Research Center, Badr University in Cairo, Badr City, Cairo 11829, Egypt
| | - Nadeen H Diab
- Department of Pharmacognosy, Faculty of Pharmacy, Assiut University, Assiut 71526, Egypt
| | - Nahla A Abdelshafi
- Department of Pharmaceutical Analytical Chemistry, School of Pharmacy, Badr University in Cairo, Badr City, Cairo 11829, Egypt
| | - Mohamed A Shaheen
- Department of Histology & Cell Biology, Faculty of Medicine, Zagazig University, Zagazig 44519, Egypt
| | - Mahmoud Elsabahy
- Badr University in Cairo Research Center, Badr University in Cairo, Badr City, Cairo 11829, Egypt; Department of Chemistry, Texas A&M University, College Station, TX 77842, USA.
| | - Sally K Hammad
- Department of Biochemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt
| |
Collapse
|